Literature DB >> 22232908

[Pharmacological neuroprotection against brain damage in ischemiai/reperfusion experiment].

V I Petrov, É A Ponomarev, S S Maskin, N N Strepetov.   

Abstract

Experiment carried out on laboratory animals (rats) were aimed at comparative evaluation of the effect of several neuroprotective drugs under the conditions of model brain ischemia-reperfusion. The experimental methods included staining of brain tissue sections by hematoxiline-eosine, Nissl staining, and expression of NOS1, NOS3, TRAIL by imunnohistological means. The intensity of damage in various parts of brain and the nature of apoptosis without neuroprotection and with popular neuroprotectors (cytoflavin, actovegin, mexidol) and a test drug at the stage ofpreclinical trial (AKF-90-7) were evaluated. Characteristic cytotoxic (coagulative pycnomorphic and colliquative necrosis of neurons) and vascular (hemostasia, erythropedesis) changes were revealed. The neuroprotective effectof drugs decreases in the following order: AKF-90-7 > cytoflavin > actovegin > mexidol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22232908

Source DB:  PubMed          Journal:  Eksp Klin Farmakol        ISSN: 0869-2092


  2 in total

1.  Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia.

Authors:  Beibei Dong; Min Cai; Zongping Fang; Haidong Wei; Fangyun Zhu; Guochao Li; Hailong Dong; Lize Xiong
Journal:  BMC Neurosci       Date:  2013-06-10       Impact factor: 3.288

2.  Hemopexin alleviates cognitive dysfunction after focal cerebral ischemia-reperfusion injury in rats.

Authors:  Beibei Dong; Yongyan Yang; Zhishen Zhang; Keliang Xie; Lin Su; Yonghao Yu
Journal:  BMC Anesthesiol       Date:  2019-01-15       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.